Showing 1 - 10 of 1,692
Health alert issued over 'soil fever'
News, Post Reporters, Published on 30/05/2025
» A public health warning has been issued over an outbreak of melioidosis, also known locally as "soil fever", after three deaths were reported in Maha Sarakham, according to the provincial public health office.
Thammasat, Novo Nordisk Unite for Holistic Diabetes, Obesity Care
Published on 28/05/2025
» Thammasat University Hospital, in collaboration with Novo Nordisk Pharma (Thailand) Ltd. (“Novo Nordisk”), announced a collaboration titled “Partnership Project for the Transition into the Fourth Decade of Thammasat University Hospital: Beat Obesity Beat Diabetes” at the Thammasat University Hospital. The public-private partnership aims to enhance holistic patient care and expand equitable access for all.
Thailand and Saudi Arabia Boost Wellness Partnership
Published on 23/05/2025
» In a landmark move to enhance bilateral cooperation in healthcare and wellness, the Royal Thai Embassy in Riyadh recently hosted a high-profile seminar titled “Wellness Hub Thailand: The Future of Global Wellness.” The event, held under the patronage of H.E. Mr. Darm Boontham, Ambassador of Thailand to Saudi Arabia, spotlighted Thailand’s growing role as a global wellness leader and aligned closely with the Kingdom of Saudi Arabia’s strategic Vision 2030 agenda.
Novo Nordisk Leads Obesity Fight in Thailand
Published on 20/05/2025
» Bangkok, May 2025 – Novo Nordisk, the global pharmaceutical leader headquartered in Denmark, has launched a major initiative to combat Thailand’s growing obesity crisis, where more than 40% of the population is now classified as overweight or obese.
Sanofi Leads Regional Effort to Safeguard Flu Vulnerable
Published on 20/05/2025
» Bangkok, Thailand – Sanofi, a global leader in biopharmaceutical innovation, recently hosted a hybrid symposium titled "Safeguarding High-Risk Groups: The Importance of Flu Prevention and Effective Communication." The event brought together 380 healthcare professionals from across Southeast Asia and India to address the burden of influenza among vulnerable populations and shared strategies for improving health outcomes.
Novo Nordisk Launches Campaign to Tackle Obesity
Published on 20/05/2025
» Novo Nordisk Pharma (Thailand) Ltd. is advancing its commitment to sustainable weight management among Thais through the launch of the “From My Weight to My Heart” campaign, aimed at reducing the risk of cardiovascular diseases and non-communicable diseases (NCDs)—key global health challenges. The campaign debuted with an inspirational panel featuring leading public figures.
Thailand's obesity epidemic is worsening
Business, Published on 19/05/2025
» Thailand is grappling with a growing obesity epidemic, raising concerns among health professionals about the surge in related non-communicable diseases (NCDs) and the increasing strain on the nation's healthcare system.
Bangkokians are fattest Thais
Post Reporters, Published on 19/05/2025
» More than 56% of people living in Bangkok suffer from abdominal obesity, putting them at greater risk of non-communicable diseases (NCDs) than those living in other provinces, said Public Health Minister Somsak Thepsutin.
Gerard Depardieu: a tarnished French film icon
AFP, Published on 13/05/2025
» PARIS - Gerard Depardieu was a titan of French cinema for more than 50 years but a sexual assault conviction, a string of other allegations and several instances of lewd behaviour now cast a long, dark shadow over what was once a glittering career.
Novo Nordisk, Nanyang Launch Shoes for Haemophilia Awareness
Published on 08/05/2025
» Bangkok, Thailand – 6 May 2025 – Novo Nordisk Pharma (Thailand) Ltd. (Novo Nordisk), a global healthcare company committed to driving change in chronic diseases, has announced the delivery of unique shoes, produced in collaboration with renowned Thai shoe manufacturer Nanyang, to the Thai Haemophilia Patient Club. The collaboration aims to enhance awareness of haemophilia in Thailand, underscoring the message of equitable access to healthcare.